Yi Shu1, Bing Wang, Ji Wang, Jian-Ming Wang, Sheng-Quan Zou. 1. General Surgery Department of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei Province, China.
Abstract
AIM: To identify methylation profile and novel tumor marker of extrahepatic cholangiocarcinoma (CCA) with high throughout microarray. METHODS: Differential methylation profile was compared between normal bile duct epithelial cell lines and CCA cell lines by methyl-DNA immunoprecipitation (MeDIP) microarray. Bisulfite-polymerase chain reaction (BSP) was performed to identify the methylated allels of target genes. Expression of target genes was investigated before and after the treatment with DNA demethylating agent. Expression of candidate genes was also evaluated by immunofluorescence in 30 specimens of CCA tissues and 9 normal bile duct tissues. RESULTS: Methylation profile of CCA was identified with MeDIP microarray in the respects of different gene functions and signaling pathways. Interestingly, 97 genes with hypermethylated CpG islands in the promoter region were homeobox genes. The top 5 hypermethylated homeobox genes validated by BSP were HOXA2 (94.29%), HOXA5 (95.38%), HOXA11 (91.67%), HOXB4 (90.56%) and HOXD13 (94.38%). Expression of these genes was reactivated with 5'-aza-2'-deoxycytidine. Significant expression differences were found between normal bile duct and extrahepatic CCA tissues (66.67%-100% vs 3.33%-10%). CONCLUSION: HOXA2, HOXA5, HOXA11, HOXB4 and HOXD13 may work as differential epigenetic biomarkers between malignant and benign biliary tissues.
AIM: To identify methylation profile and novel tumor marker of extrahepatic cholangiocarcinoma (CCA) with high throughout microarray. METHODS: Differential methylation profile was compared between normal bile duct epithelial cell lines and CCA cell lines by methyl-DNA immunoprecipitation (MeDIP) microarray. Bisulfite-polymerase chain reaction (BSP) was performed to identify the methylated allels of target genes. Expression of target genes was investigated before and after the treatment with DNA demethylating agent. Expression of candidate genes was also evaluated by immunofluorescence in 30 specimens of CCA tissues and 9 normal bile duct tissues. RESULTS: Methylation profile of CCA was identified with MeDIP microarray in the respects of different gene functions and signaling pathways. Interestingly, 97 genes with hypermethylated CpG islands in the promoter region were homeobox genes. The top 5 hypermethylated homeobox genes validated by BSP were HOXA2 (94.29%), HOXA5 (95.38%), HOXA11 (91.67%), HOXB4 (90.56%) and HOXD13 (94.38%). Expression of these genes was reactivated with 5'-aza-2'-deoxycytidine. Significant expression differences were found between normal bile duct and extrahepatic CCA tissues (66.67%-100% vs 3.33%-10%). CONCLUSION:HOXA2, HOXA5, HOXA11, HOXB4 and HOXD13 may work as differential epigenetic biomarkers between malignant and benign biliary tissues.
Entities:
Keywords:
Cholangiocarcinoma; DNA methylation; Epigenetic; Promoter microarray
Authors: Heidi Fiegl; Gudrun Windbichler; Elisabeth Mueller-Holzner; Georg Goebel; Matthias Lechner; Ian J Jacobs; Martin Widschwendter Journal: Int J Cancer Date: 2008-08-01 Impact factor: 7.396
Authors: Oliver Hartmann; Frédérique Spyratos; Nadia Harbeck; Dimo Dietrich; Anne Fassbender; Manfred Schmitt; Serenella Eppenberger-Castori; Vincent Vuaroqueaux; Florence Lerebours; Katrin Welzel; Sabine Maier; Achim Plum; Stephan Niemann; John A Foekens; Ralf Lesche; John W M Martens Journal: Clin Cancer Res Date: 2009-01-01 Impact factor: 12.531
Authors: V Branchi; P Schaefer; D Dietrich; H Matthaei; A Semaan; A Kania; P Lingohr; J C Kalff; N Schäfer; G Kristiansen Journal: Clin Epigenetics Date: 2016-12-12 Impact factor: 6.551
Authors: John B Kisiel; Jia Li; Hongzhi Zou; Abdul M Oseini; Benjamin B Strauss; Kadra H Gulaid; Catherine D Moser; Ileana Aderca; David A Ahlquist; Lewis R Roberts; Abdirashid M Shire Journal: J Mol Biomark Diagn Date: 2013-08-03